Literature DB >> 6224386

Hyperinsulinism and insulin resistance in polycystic ovarian syndrome: a verification using oral glucose, I.V. Glucose and tolbutamide.

G Cotrozzi, M Matteini, P Relli, T Lazzari.   

Abstract

Twenty-six female in-patients, aged 14-34 years, suffering from polycystic ovarian syndrome (PCOS) were investigated. Sixteen normal women, matched with patients for age and weight, were used as controls. Both glucose and insulin curves and areas, insulin/glucose area ratio [insulin resistance index (IA/GA)] were studied by oral glucose tolerance test (OGTT), i.v. glucose tolerance test (IVGTT) and tolbutamide test (TT). Plasma insulin and insulin area values of the patients were significantly higher than those of controls. Insulin/glucose area ratios were significantly higher in patients when compared to controls. A correlation was found in some patients (subgroup A) between insulin/glucose area ratio and urinary dehydroepiandrosterone output after the TT. The presence of hyperinsulinism and insulin resistance in our patients suffering from PCOS was confirmed even in the absence of obesity. A relationship between androgens and hyperinsulinism and insulin resistance may thus be confirmed in patients with PCOS.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6224386     DOI: 10.1007/bf02624914

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  7 in total

Review 1.  Hirsutism and hyperandrogenism.

Authors:  J R Givens
Journal:  Adv Intern Med       Date:  1976

2.  Remission of acanthosis nigricans associated with polycystic ovarian disease and a stromal luteoma.

Authors:  J R Givens; I J Kerber; W L Wiser; R N Andersen; S A Coleman; S A Fish
Journal:  J Clin Endocrinol Metab       Date:  1974-03       Impact factor: 5.958

3.  Insulin resistance, skin changes, and virilization: a recessively inherited syndrome possibly due to pineal gland dysfunction.

Authors:  N D Barnes; P J Palumbo; A B Hayles; H Folgar
Journal:  Diabetologia       Date:  1974-08       Impact factor: 10.122

4.  The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man.

Authors:  C R Kahn; J S Flier; R S Bar; J A Archer; P Gorden; M M Martin; J Roth
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

5.  Demonstration of a primary (? genetic) defect in insulin receptors in fibroblasts from a patient with the syndrome of insulin resistance and acanthosis nigricans type A.

Authors:  C R Kahn; J M Podskalny
Journal:  J Clin Endocrinol Metab       Date:  1980-06       Impact factor: 5.958

6.  Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease.

Authors:  G A Burghen; J R Givens; A E Kitabchi
Journal:  J Clin Endocrinol Metab       Date:  1980-01       Impact factor: 5.958

7.  Glucose intolerance and insulin resistance in aplastic anemia treated with oxymetholone.

Authors:  T L Woodard; G A Burghen; A E Kitabchi; J A Wilimas
Journal:  J Clin Endocrinol Metab       Date:  1981-11       Impact factor: 5.958

  7 in total
  7 in total

1.  Further delineation of familial polycystic ovary syndrome (PCOS) via whole-exome sequencing: PCOS-related rare FBN3 and FN1 gene variants are identified.

Authors:  Cengiz Karakaya; Aylin Pelin Çil; Kaya Bilguvar; Tunahan Çakir; Mete Hakan Karalok; Recep Onur Karabacak; Ahmet Okay Caglayan
Journal:  J Obstet Gynaecol Res       Date:  2022-02-09       Impact factor: 1.697

Review 2.  Genetics of the polycystic ovary syndrome.

Authors:  Gülüm Kosova; Margrit Urbanek
Journal:  Mol Cell Endocrinol       Date:  2012-10-16       Impact factor: 4.102

3.  Insulin resistance and secretion in polycystic ovarian disease.

Authors:  B Bruno; G Poccia; A Fabbrini
Journal:  J Endocrinol Invest       Date:  1985-10       Impact factor: 4.256

4.  Evaluating compliance to a low glycaemic index (GI) diet in women with polycystic ovary syndrome (PCOS).

Authors:  Nicola Egan; Anna Read; Paddy Riley; William Atiomo
Journal:  BMC Res Notes       Date:  2011-03-08

5.  Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome.

Authors:  Mariona Jové; Irene Pradas; Alba Naudí; Susana Rovira-Llopis; Celia Bañuls; Milagros Rocha; Manuel Portero-Otin; Antonio Hernández-Mijares; Victor M Victor; Reinald Pamplona
Journal:  Oncotarget       Date:  2017-12-17

6.  The Investigation of Polymorphisms in DNA Repair Genes (XRCC1, APE1 and XPD) in Women with Polycystic Ovary Syndrome

Authors:  Gonca Gulbay; Elif Yesilada; Onder Celik; Saim Yologlu
Journal:  Asian Pac J Cancer Prev       Date:  2017-05-01

Review 7.  Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review.

Authors:  Sarantis Livadas; Panagiotis Anagnostis; Julia K Bosdou; Dimitra Bantouna; Rodis Paparodis
Journal:  World J Diabetes       Date:  2022-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.